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Abstract
Objectives
The aim of this study is to investigate the association between age, gender, body-mass
index, smoking behavior, orthopedic comorbidity, neurologic comorbidity, cardiac comor-
bidity, vascular comorbidity, pulmonic comorbidity, internal comorbidity and Initial Claudica-
tion Distance during and after Supervised Exercise Therapy at 1, 3, 6 and 12 months in a
large sample of patients with Intermittent Claudication.
Methods
Data was prospectively collected in standard physiotherapy care. Patients received Super-
vised Exercise Therapy according to the guideline Intermittent Claudication of the Royal
Dutch Society for Physiotherapy. Three-level mixed linear regression analysis was carried
out to analyze the association between patient characteristics, comorbidities and Initial
Claudication Distance at 1, 3, 6 and 12 months.
Results
Data from 2995 patients was analyzed. Results showed that being female, advanced age
and a high body-mass index were associated with lower Initial Claudication Distance at all-
time points (p = 0.000). Besides, a negative association between cardiac comorbidity and
Initial Claudication Distance was revealed (p = 0.011). The interaction time by age, time by
body-mass index and time by vascular comorbidity were significantly associated with Initial
Claudication Distance (p 0.05). Per year increase in age (range: 33–93 years), the
reduction in Initial Claudication Distance was 8m after 12 months of Supervised Exercise
Therapy. One unit increase in body-mass index (range: 16–44 kg/m2) led to 10m less
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improvement in Initial Claudication Distance after 12 months and for vascular comorbidity
the reduction in improvement was 85m after 12 months.
Conclusions
This study reveals that females, patients at advanced age, patients with a high body-mass
index and cardiac comorbidity are more likely to show less improvement in Initial Claudica-
tion Distances (ICD) after 1, 3, 6 and 12 months of Supervised Exercise Therapy. Further
research should elucidate treatment adaptations that optimize treatment outcomes for
these subgroups.
Introduction
Identifying subgroups of patients who benefit less from physiotherapy treatment is a crucial
preparatory step to be able to early adjust treatment expectation and treatment programme.
The primary treatment modality for patients with Peripheral Arterial Disease (PAD) is physio-
therapy and practice results show a high variety in treatment outcome.
Peripheral Arterial Disease in the leg(s) is a manifestation of narrowing or blockage of arter-
ies (atherosclerosis) that causes poor blood flow to the lower extremities. The clinical spectrum
of patients ranges from asymptomatic atherosclerosis to those with the common symptoms of
Intermittent Claudication (IC), e.g. tight, aching, or squeezing pain in the calf, thigh or buttock.
Symptoms occur when the delivery of oxygen is inadequate to meet the metabolic requirements
of the active skeletal muscle [1]. Leg pain is relieved by rest. Intermittent Claudication leads to
a moderate or severe impairment in walking ability. In order to improve walking ability, Super-
vised Exercise Therapy (SET) by a physical therapist is recommended as the primary training
modality for this patient group [2–4]. Walking limitation is measured by the Initial Claudica-
tion Distance (ICD), the distance at which the patient experiences the onset of claudication
pain and the Absolute Claudication Distance (ACD), the distance at which the pain forces the
patient to stop walking [3].
A few small scale studies indicate that patient characteristics and comorbid conditions
might lead to considerably poorer treatment outcomes during and after SET [5–10]. For exam-
ple, Katzel et al. [6] (N = 141) pointed out that current smokers had a shorter time to onset of
claudication pain compared to former or never smokers (188± 28 s vs. 173±25 s and 309± 54 s,
respectively; p = 0.023). A reduced improvement after conservative treatment by risk factor
modification and physical training for female patients (hazard ratio (HR) 0.51; p = 0.052) was
presented by Amighi et al. [7] (N = 181). Dolan et al. [8] (N = 460) observed that after adjusting
for age, PAD patients with diabetes type 2 had a shorter mean 6-min walking distance (1,040
vs. 1,168 feet; p<0.001). A recent study of Farah et al. [9] (N = 415) explored that Cardiovascu-
lar Disease (CVD) was associated with lower ACD and ICD (OR = 2.45; CI:1.11–5.39 and
OR = 1.88; CI:0.86–4.09, respectively) and age, body-mass index (BMI), pulmonary disease
and smoking behavior were predictive variables for ACD that were presented by Kruidenier
et al. [10]. Taken together, from a scientific point of view these studies seem to provide compel-
ling evidence that specific patient characteristics and comorbidity influence physiotherapy
treatment success in patients with IC. However, all previous investigations were based on small
numbers of patients (maximum N = 460 [7]) largely recruited in the hospital setting. By the use
of our large cohort we want to check whether the hampering effects of patient-related variables
and comorbidity remain in place in a large population of patients with IC that follow SET in
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the usual care setting. Moreover, the large sample size of our cohort makes it possible to use a
multilevel model through which it can be acknowledged that patients received treatment by
different physiotherapists [11].
If the results of our large physiotherapy cohort show that the inverse association between
patient characteristics and comorbidity (as identified in earlier small scale studies) remains, sub-
groups of patients that benefit less from SET can most certainly be identified. The aim of this
study is to investigate the association between age, gender, BMI, smoking behavior, orthopedic
comorbidity, neurologic comorbidity, cardiac comorbidity, vascular comorbidity, pulmonic
comorbidity, internal comorbidity and initial claudication distance (ICD) during and after super-
vised treadmill exercise at 1, 3, 6 and 12 months in a large physiotherapy cohort study.
Methods
Study design and setting
To study the association between patient characteristics and comorbidity on Initial Claudica-
tion Distance (ICD) analyses on prospectively collected Electronic Medical Record (EMR) data
was performed. Registration of the patients’ medical data in the EMR was part of standard
physiotherapy care. Data from patients with IC that were treated with community-based super-
vised exercise therapy (SET) between 2006 and 2011 was used for this study. The ethics com-
mittee/institutional review board 'Medisch Ethische Toetsingscommissie van Atrium Medisch
Centrum, Orbis Medisch en Zorgconcern en Zuyd Hogeschool' approved at August, 19th 2013
the present physiotherapy cohort study. Data was gathered in the context of usual care. All par-
ticipants signed written informed consent for their clinical records to be used in the present
physiotherapy cohort study and patient records/information was anonymized and de-identi-
fied prior to analysis (METC number: 13-N-85). To enhance transparency this article is written
according to the STROBE checklist for cohort studies.
Participants
All patients with a physician confirmed IC who started community-based SET were eligible for
inclusion. The diagnosis of IC was confirmed with an ankle-brachial index (ABI)<0.9 at rest.
Exclusion criteria were the absence of a baseline measurement, less than one valid ICD mea-
surement and ICD of 1600 meters or more at baseline [12]. A cut-off value for all ICD was set
at 1600m. For practical reasons incline and testing duration in standard practice are maximized
to 30 minutes (1600m).
Variables
The primary outcome measurement was ICD at 1, 3, 6 or 12 months of SET. In recent years,
there has been an increased focus on patient-centered care, defined by the Institute of Medicine
(IOM) as ‘providing care that is respectful of and responsive to individual patient preferences,
needs, and values, and ensuring that patient values guide all clinical decisions’ [13]. The hin-
drance of patients with IC is that they are limited by pain while walking. During physiotherapy
treatment patients are instructed to walk as far as they can through the pain (ACD), until clau-
dication pain becomes so severe that the patient is forced to stop [4]. However, the ACD does
not correspond with the distance a patient would walk in the course of daily activities as few
will by choice walk until their maximum pain threshold. To acknowledge the importance of
the patients’ wish to walk longer distances pain-free this study focuses on Initial Claudication
Distance (ICD) as primary outcome to reveal determinants of walking distance in standard
physiotherapy care. Independent variables include age, gender and the physiotherapy practice.
Co-Factors Influence Treatment Outcome
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Besides, BMI of each patient was calculated as weight (kg)/height squared (m2) according to
the clinical guideline on the Identification, Evaluation and Treatment of Overweight and Obe-
sity in Adults [14]. Smoking behaviour was recorded as non-smoker, previous smoker and cur-
rent smoker. Presence or absence of orthopaedic-, neurologic-, cardiac-, pulmonic- and
internal comorbidity was registered according to the standard hospital registration. Besides,
the presence or absence of vascular comorbidity was registered in the same way. As patients
with IC already suffer from a vascular disease in the category vascular comorbidity solely the
presence or absence of Percutaneous Transluminal Angioplasty (PTA), recanalization, bypass
operation, endarterectomy, hypertension, arrhythmia, cardiac decompensation and heart valve
suffering was recorded. Detailed information about specific diseases that belong to the other
mentioned five categories of comorbidity is reported in S1 File. Patient-related variables and
comorbidity were evaluated at baseline.
Data source
Data for this cohort study was derived from prospectively collected data filled in by physiother-
apists in electronic medical records as part of standard care. This registration tool was
commissioned by the centre of evidence-based physiotherapy (www.cebp.nl) and realised by
Convenience-Fastguide1 (www.fastguide.eu). All patients provided their informed consent to
register and use their medical data.
Supervised Exercise Therapy
All patients received SET according to the evidence-based IC guideline of the Royal Dutch
Society for Physiotherapy [12] as part of usual care. A standardised graded treadmill test with a
constant speed of 3.2 km/h according to Gardner et al. [15] was used as measure of ICD. The
incline starts at 0% and is increased by 2% every two minutes. The ICD was evaluated by the
physiotherapist at baseline and after 1, 3, 6 and 12 months of follow-up. All measurements
were registered in the EMR by the physiotherapist. Detailed information on the community-
based exercise program has previously been published by our research group [16,17].
Statistical methods
Data was analysed with a three-level mixed linear regression analysis. The three levels were
physiotherapist, patients within therapists, and measurements within patients. Time and
patient characteristics (gender, age, smoking status, BMI, comorbidity) were included as fixed
effects. The continuous predictors age and BMI were centred by subtracting from age 68 years
(median age in the sample) and from BMI 25 kg/m2 (clinical cut-off for overweight; close to
median 26 in sample), to allow interpretation of time effects on the outcome if there is interac-
tion of age or BMI with time [18]. All categorical predictors were entered through dummy indi-
cator coding, with as reference categories respectively baseline for time, non-smoker for
smoking status, male for gender, and absence of disease for each comorbidity. Interactions of
time with each patient characteristic were included in the model. Finally, outcome differences
between therapists were included as a random intercept, and outcome differences between
patients (as far as unexplained by the predictors) were accommodated by allowing for an
unstructured covariance pattern of the repeated measures. The model was subsequently simpli-
fied by excluding non-significant interaction effects (α .05) from the model one-by-one. All
available measurements of all patients were analysed without imputation for missing measure-
ments, which is valid under the same assumptions as multiple imputation, and under less
restrictive assumptions than complete cases analysis or simple imputation methods [18]. Val-
ues of all repeated measures in maximum pain-free walking distance after the first occurrence
Co-Factors Influence Treatment Outcome
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of the cut-off value ICD = 1600m were reset to missing because of a maximized incline and
testing duration of 30 minutes (1600m) in standard physiotherapy practice. Outcome measures
were checked for normality. Predictors were checked for outliers (summary descriptive statis-
tics and histograms) and multicollinearity by inspecting their Variance Inflation Factor (VIF)
[19]. No VIFs above 10 were found, indicating absence of multicollinearity [20]. Further, in
view of the skewed distribution of the outcome, two additional analyses to check the robustness
of the results were performed. First, BMI was left out of the analysis (30% missing values), lead-
ing to the inclusion of 1254 more patients into the analysis. Third and last, the outcome was
dichotomized as 1 if ICD = 1600m and as 0 if ICD< 1600m, and was analysed with mixed
logistic regression using the same modelling procedure as in the mixed linear regression of the
continuous ICD measure. The results of the additional analyses were compared with the first
analysis. In view of multiple testing, significant results are presented at the 1% and the 5% sig-
nificance level, and results significant at the 5% level but not at the 1% level must be treated as
tentative pending replication.
Results
Descriptive data of participants
The inclusion criteria were met by 2995 patients. The average age of patients was 67 years.
Comorbidities that were present in more than half of all patients were vascular comorbidity
(62%), internal comorbidity (54%) and cardiac comorbidity (49%). Mean initial claudication
distance (ICD) at baseline was 270m and after 12 months of SET 667m. The characteristics of
the study population are described in Table 1.
The results of the three-level mixed linear regression analysis showed at a 1% significance
level that being female (p = 0.000), advanced age (p = 0.000) and a high BMI (p = 0.000) lead to
less improvement in ICD after SET. Cardiac comorbidity seemed to be associated with
improvement in ICD at a 5% level (p = 0.011). In addition, all three interaction terms, time by
age (p = 0.000), time by vascular comorbidity (p = 0.023) and time by BMI (p = 0.023) were sig-
nificantly associated with ICD progress (Table 2). Interactions gendertime and smokingtime
were tested but were not significant.
For females the predicted ICD is 41m less than for males after 12 months of SET. For
patients with a cardiac comorbidity, the predicted ICD is 30m less after 12 months compared
to patients without a cardiac comorbidity. Both interpretations apply when all other variables
are kept constant.
To calculate the improvement in ICD from baseline to IC at 1, 3, 6 and 12 months for the
interactions with time the following regression equation was used:
Change in ICD1;3;6;12months
¼ B1tð1; 3; 6; 12Þdumþ b2timeageðcenteredÞ þ b3timeBMIðcenteredÞ
þ b4timevascularcomorbidity:
In general terms, per year increase in age (range 33–93) ICD improvement is 8 meters less
after 12 months. Per unit increase of BMI (range: 16–46) the improvement of ICD is 10 meters
less after 12 months and the presence of vascular comorbidity leads to 85 meters less improve-
ment after 12 months of SET. In all three scenarios all other variables are hold constant. Fig A,
Fig B and Fig C in S2 File provide plots of predicted values for the total sample per subgroup of
age, BMI and vascular comorbidity to visualize interactions with time.
To check the robustness of our findings two additional analysis were performed. First, we
eliminated BMI from the model (30% missing values), resulting in 1254 more patients in the
Co-Factors Influence Treatment Outcome
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Table 1. Characteristics of the study population.
Characteristica Total population Males Females
N = 2995b N = 1864 N = 1131
Age, years 67.4 ± 9.9 67.0 ± 9.5 68.2 ± 10.4
BMI, kg/m2 26.8 ± 4.3 26.8 ± 4.0 26.6 ± 4.7
Current smokers 1140 (41.5) 708 (41.5) 432 (41.5)
Orthopaedic comorbidity 570 (23.8) 325 (21.9) 245 (26.9)
Neurological comorbidity 555 (23.6) 353 (24.2) 202 (22.6)
Cardiac comorbidity 1163 (48.7) 756 (50.8) 407 (45.2)
Vascular comorbidity 1474 (61.6) 909 (61.0) 565 (62.5)
Pulmonary comorbidity 408 (17.9) 270 (19.1) 138 (16.0)
Internal comorbidity 1242 (54.4) 755 (53.2) 487 (56.4)
Baseline ICD, meter 269.6 ± 227.3 286.1 ± 235.8 242.8 ± 210.1
1 months ICD, meter 433.6 ± 333.4 456.4 ± 348.7 394.5 ± 301.5
3 months ICD, meter 531.9 ± 380.9 554.5 ±394.4 496.0 ± 355.6
6 months ICD, meter 605.3 ± 411.6 632.9 ± 420.0 562.8 ± 394.9
12 months ICD, meter 667.1 ± 446.1 672.8 ±448.1 658.2 ± 443.3
BMI: Body-Mass Index; ICD = Initial Claudication Distance
aDichotomous variables are presented as N (%) and continuous variables as mean ± standard deviation; ICD is reported as median ± standard deviation.
bN = 2995 is the maximum amount of patients that were included in one of our analysis.
doi:10.1371/journal.pone.0146828.t001
Table 2. Final mixed linear model.
Fixed- effects [N = 1741] Estimate SE t-value p-value 95% Conﬁdence Interval
Lower Upper
Intercept 315.48 22.869 13.80 0.000 270.59 360.37
Gender -40.72 11.613 -3.51 0.000 -63.50 -17.94
Agea -4.06 0.601 -6.75 0.000 -5.24 -2.88
BMIa -4.68 1.338 -3.50 0.000 -7.30 -2.06
Past smokerb 19.06 19.109 1.00 0.319 -18.43 56.54
Current smokerb -34.27 19.930 -1.72 0.086 -73.36 4.82
Orthopaedic comorbidity 5.32 13.585 0.39 0.695 -21.32 31.97
Neurological comorbidity -4.17 13.483 -0.31 0.757 -30.61 22.27
Cardiac comorbidity -29.55 11.549 -2.56 0.011 -52.20 -6.90
Vascular comorbidity -11.00 11.288 -0.98 0.330 -33.15 11.14
Pulmonary comorbidity -17.94 14.875 -1.21 0.228 -47.12 11.24
Internal comorbidity -9.14 11.708 -0.78 0.435 -32.11 13.82
Time 1 dummy 165.95 7.527 22.05 0.000 151.19 180.71
Time 3 dummy 305.16 11.238 27.15 0.000 283.12 327.21
Time 6 dummy 439.01 18.214 24.10 0.000 403.27 474.75
Time 12 dummy 584.84 29.593 19.76 0.000 526.72 642.97
Age*time -0.63 0.158 -3.98 0.000 -0.94 -0.32
BMI*time -0.82 0.359 -2.28 0.023 -1.52 -0.11
Vascular comorbidity*time -7.07 3.102 -2.28 0.023 -13.17 -0.98
Dependent Variable: ICD (Initial Claudication Distance).
doi:10.1371/journal.pone.0146828.t002
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analysis. The results of this analysis were in agreement with the results of the mixed linear
model described in Table 2. Second, in view of non-normality of ICD the analysis was repeated
by using a mixed logistic regression model after dichotomizing ICD as 1 if ICD = 1600m and
as 0 if ICD<1600m. In accordance with the linear analysis, the results showed that being
female (p = 0.000), advanced age (p = 0.000) and a high BMI (p = 0.000) were associated with
shorter ICD at all-time points. Furthermore, for current smoking (p = 0.031) and vascular
comorbidity there seemed to be a negative association with ICD (p = 0.006). None of the inter-
action terms were significant, probably due to loss of power by dichotomization.
Discussion
This study showed that female gender, advanced age, a high BMI and cardiac comorbidity are
associated with less improvement in Initial Claudication Distances (ICD) after 1, 3, 6 and 12
months of Supervised Exercise Therapy (SET). In addition, the interaction time by age, time by
BMI and time by vascular comorbidity were significantly associated with ICD. Additional anal-
ysis showed that there might be a negative association between vascular comorbidity and ICD
and well as between cigarette smoking and ICD.
Some limitations are worth noting. First, due to the cross-sectional design of this study no
causality can be inferred. Second, the absence of a control group and a randomisation proce-
dure prevents interpretation of time effects as treatment effects. Time effects may also have
been detected due to spontaneous recovery or treatments patients follow or experience outside
the physiotherapy setting. Third, comorbidity was registered at the first visit, hence before the
start of SET. Therefore, it was not possible to investigate whether the presence of comorbid dis-
eases changed over time. Fourth, the exact training program for each individual patient was
not recorded. In general, the recommendations stated in the guideline Intermittent Claudica-
tion (IC) of the Royal Dutch Society for Physiotherapy are used to treat patients with PAD.
However, we have no information about whether the general recommendation was adjusted
for an individual patient. Therefore, the influence of variance in treatment on ICD after SET
could not be investigated.
Noteworthy is the fact that this study highlights a significant association with ICD for age,
gender, BMI, and cardiovascular comorbidity at one go. When looking at previous research,
the hampering association of all these factors already has been established [5–10]. However, it
was spread throughout different studies, each presenting the adverse effect of one or two
patient characteristics and/or comorbidity on walking distance in patients with IC. A possible
explanation might be that the sample sizes of previous studies were relatively small (maximum
N = 460 [6]) in comparison with our study (N = 2995). Furthermore, for this study patients
were not intentionally recruited, but data from EMRs was used, which allowed the research
team to investigate which patient characteristics and comorbidity affect ICD in the standard
physiotherapy care setting.
The inverse association between anthropometric indices like gender, age and BMI and walk-
ing distance has been previously studied. To illustrate, Troosters et al. [21] highlighted that
66% of the variability in walking distance assessed by the six-minute walk test in healthy partic-
ipants aged 50–85 years is attributable to age, gender and BMI. Applying these finding to
patients with IC, a systematic review of Robeer et al. [22] showed that older patients respond
less favourably to SET compared to their younger counterparts. Changes in the cardiovascular
system that occur with aging might explain why advanced age reduces the improvement in
ICD after SET. Alterations in cardiovascular physiology like a reduction in a heart’s peak
capacity to pump blood by 5% to 10% per decade might cause a diminished aerobic capacity
with increasing age. Furthermore, with advanced age, the elasticity of arteries decreases and
Co-Factors Influence Treatment Outcome
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vascular walls thicken. This results in a slower exchange between oxygen and waste products
[23]. As intermittent claudication is already associated with a decreased blood flow to the lower
extremities particular during times of increased metabolic demand such as during SET, above
mentioned age-related cardiovascular adaptations might worsen muscle oxygen supply. Thus,
the combination of PAD and age-related cardiovascular adaptations might cause oxygen ische-
mia faster; the muscle may not receive as much oxygen as needed to support physical activity
and this might explain why ICD is lower in older patients with IC compared to their younger
counterparts. The capacity to perform aerobic exercise also depends on the ability of the heart
to augment its output to the exercising muscles. This ability is often impaired in patients with
cardiac comorbidity. Results of the present study show that patients with cardiac comorbidity
show fewer improvements in ICD after SET, which might be caused by inadequate blood flow
to the active skeletal muscle secondary to impaired cardiac output. Research has shown that
patients with cardiac diseases may achieve less than 50% of the maximum cardiac output
attained by individuals without cardiac disease [24].
Regarding the inverse association between a high BMI and less improvement in ICD after
SET, previous research reported that BMI is a predictor of walking ability and functional capac-
ity. Overall, it seems that increased body mass, either around the hip and thighs (gynoid obe-
sity) or around the belly (android obesity) reduces walking ability and has a negative impact on
functional capacity. The results of studies whether high fat mass or low lean mass are more
important in the association between obesity and walking capacity remain contradictory. A
study by Jankowski et al. [25] and a study by Davison et al. [26] found that a higher fat-mass is
more important than low lean mass in the association with mobility-related disability. In con-
trast, a study of Newman et al. [24] showed an independent effect of low lean mass on walking
ability.
The results of the present study also report that females show less improvement in ICD
compared to males. Microvascular gender differences in patients with IC have been previously
reported and might explain the differential improvement in ICD between men and women
[27,28]. A lower haemoglobin oxygen saturation of the calf muscles combined with a more
impaired microvascular function seems to cause greater muscle ischemia during SET in
women compared to men [27,28]. Other general gender-based biochemical differences like
higher levels of oxidative stress and inflammation that are common in postmenopausal women
might also contribute to lower improvements in ICD [27]. Nevertheless, other differences such
as motivation, willingness to walk through claudication pain and pain tolerance threshold
might be additional explanatory factors.
To check the robustness of our findings among others mixed logistic regression analysis was
performed. This analysis was the only supplementary analysis reporting that addionally current
smoking and vascular comorbidity seemed to be associated with less improvement in ICD after
SET. Nevertheless, previous research reported that current smoking is associated with poorer
measures of exercise capacity during treadmill testing, including lower peak oxygen update and
earlier onset of claudication pain during walking. A study of Afaq et al. [29] found that current
smokers have significantly lower rates of tissue oxygenation at peak claudication distance,
which might explain the lower ICD improvements in current smokers compared to non- or
past-smokers found in this additional analysis. Peripheral factors that impact walking ability
and therefore might explain lower ICD due to vascular comorbidity may include abnormalities
in the endothelial function like vasodilatory capacity during physical activity and distribution
of cardiac output. Since only one of the additional analysis showed current smoking and vascu-
lar comorbidity being predictors of ICD, these two findings should be interpreted with caution.
Due to dichotomization of the outcome variable we lost power in the analysis, which might
also explain why none of the interaction terms was significant.
Co-Factors Influence Treatment Outcome
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In conclusion, the present study showed that being female, advanced age, high BMI and car-
diac comorbidity are associated with less improvement in ICD after SET. Because this large
prospective usual care cohort study showed that the association of all these factors remained in
place, subgroups of patients who benefit less from SET have been most certainly identified.
Taking care of these patients who benefit less from SET is a crucial preparatory step to be able
to early adjust treatment expectations and treatment programme.
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